| ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome C Ginestier, MH Hur, E Charafe-Jauffret, F Monville, J Dutcher, M Brown, ... Cell stem cell 1 (5), 555-567, 2007 | 4847 | 2007 |
| Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature E Charafe-Jauffret, C Ginestier, F Iovino, J Wicinski, N Cervera, P Finetti, ... Cancer research 69 (4), 1302-1313, 2009 | 1379 | 2009 |
| A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated … D Cameron, M Casey, M Press, D Lindquist, T Pienkowski, CG Romieu, ... Breast cancer research and treatment 112, 533-543, 2008 | 1082 | 2008 |
| Aldehyde dehydrogenase 1–Positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer E Charafe-Jauffret, C Ginestier, F Iovino, C Tarpin, M Diebel, B Esterni, ... Clinical cancer research 16 (1), 45-55, 2010 | 860 | 2010 |
| Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial H Roché, P Fumoleau, M Spielmann, JL Canon, T Delozier, D Serin, ... Journal of Clinical Oncology 24 (36), 5664-5671, 2006 | 782 | 2006 |
| Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity E Mamessier, A Sylvain, ML Thibult, G Houvenaeghel, J Jacquemier, ... The Journal of clinical investigation 121 (9), 3609-3622, 2011 | 690 | 2011 |
| How basal are triple‐negative breast cancers? F Bertucci, P Finetti, N Cervera, B Esterni, F Hermitte, P Viens, ... International journal of Cancer 123 (1), 236-240, 2008 | 669 | 2008 |
| International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ... Annals of oncology 22 (3), 515-523, 2011 | 547 | 2011 |
| Prognostic and predictive value of PDL1 expression in breast cancer R Sabatier, P Finetti, E Mamessier, J Adelaide, M Chaffanet, HR Ali, ... Oncotarget 6 (7), 5449, 2015 | 536 | 2015 |
| Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of … JY Blay, A Le Cesne, I Ray-Coquard, B Bui, F Duffaud, C Delbaldo, ... Journal of clinical oncology 25 (9), 1107-1113, 2007 | 502 | 2007 |
| Efficacy and safety of ixabepilone (BMS-247550) in a phase II study of patients with advanced breast cancer resistant to an anthracycline, a taxane, and capecitabine EA Perez, G Lerzo, X Pivot, E Thomas, L Vahdat, L Bosserman, P Viens, ... Journal of Clinical Oncology 25 (23), 3407-3414, 2007 | 446 | 2007 |
| Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters F Bertucci, S Salas, S Eysteries, V Nasser, P Finetti, C Ginestier, ... Oncogene 23 (7), 1377-1391, 2004 | 442 | 2004 |
| Integrated profiling of basal and luminal breast cancers J Adélaïde, P Finetti, I Bekhouche, L Repellini, J Geneix, F Sircoulomb, ... Cancer research 67 (24), 11565-11575, 2007 | 429 | 2007 |
| Recent trends in epidemiology of brain metastases: an overview E Tabouret, O Chinot, P Metellus, A Tallet, P Viens, A Goncalves Anticancer research 32 (11), 4655-4662, 2012 | 413 | 2012 |
| Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in patients with taxane-resistant metastatic breast cancer E Thomas, J Tabernero, M Fornier, P Conté, P Fumoleau, A Lluch, ... Journal of Clinical Oncology 25 (23), 3399-3406, 2007 | 359 | 2007 |
| Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers F Bertucci, P Finetti, N Cervera, E Charafe-Jauffret, E Mamessier, ... Cancer research 66 (9), 4636-4644, 2006 | 347 | 2006 |
| Protein expression profiling identifies subclasses of breast cancer and predicts prognosis J Jacquemier, C Ginestier, J Rougemont, VJ Bardou, E Charafe-Jauffret, ... Cancer Research 65 (3), 767-779, 2005 | 297 | 2005 |
| Gene expression profiling identifies molecular subtypes of inflammatory breast cancer F Bertucci, P Finetti, J Rougemont, E Charafe-Jauffret, N Cervera, ... Cancer research 65 (6), 2170-2178, 2005 | 291 | 2005 |
| Gene expression profiling of primary breast carcinomas using arrays of candidate genes F Bertucci, R Houlgatte, A Benziane, S Granjeaud, J Adélaïde, R Tagett, ... Human Molecular Genetics 9 (20), 2981-2991, 2000 | 289 | 2000 |
| A gene expression signature identifies two prognostic subgroups of basal breast cancer R Sabatier, P Finetti, N Cervera, E Lambaudie, B Esterni, E Mamessier, ... Breast cancer research and treatment 126, 407-420, 2011 | 274 | 2011 |
